Grace Cherry

15.2k total citations
6 papers, 83 citations indexed

About

Grace Cherry is a scholar working on Oncology, Pharmacology and Dermatology. According to data from OpenAlex, Grace Cherry has authored 6 papers receiving a total of 83 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 1 paper in Pharmacology and 1 paper in Dermatology. Recurrent topics in Grace Cherry's work include Cancer Immunotherapy and Biomarkers (4 papers), Neuroblastoma Research and Treatments (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). Grace Cherry is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Neuroblastoma Research and Treatments (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). Grace Cherry collaborates with scholars based in United States. Grace Cherry's co-authors include John Shen, Rajan P. Kulkarni, Jason Y.H. Chang, Jonathan W. Goldman, Melody Mendenhall, Bartosz Chmielowski, Antoni Ribas, Lin Du, Natalie M. Villa and Michael W. Yeh and has published in prestigious journals such as Clinical Endocrinology, Journal for ImmunoTherapy of Cancer and Therapeutic Advances in Medical Oncology.

In The Last Decade

Grace Cherry

6 papers receiving 81 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Grace Cherry United States	5	57	21	16	13	10	6	83
Valentine Heidelberger France	6	113 2.0×	28 1.3×	17 1.1×	7 0.5×	8 0.8×	10	141
Hanan M. Fathi Egypt	7	16 0.3×	28 1.3×	8 0.5×	8 0.6×	15 1.5×	21	94
Anne-Laure Breton France	4	63 1.1×	10 0.5×	9 0.6×	12 0.9×	5 0.5×	5	83
Henk van Halteren Netherlands	5	40 0.7×	6 0.3×	14 0.9×	21 1.6×	19 1.9×	8	98
Ana Matas-García Spain	4	28 0.5×	9 0.4×	23 1.4×	30 2.3×	21 2.1×	8	91
Jean Jacques De Bruycker Canada	5	15 0.3×	8 0.4×	27 1.7×	16 1.2×	12 1.2×	8	99
April Choi United States	5	25 0.4×	12 0.6×	11 0.7×	11 0.8×	4 0.4×	13	71
Yehia I. Abugabal United States	3	24 0.4×	10 0.5×	13 0.8×	26 2.0×	6 0.6×	12	80
Aleksandra Edmundson Australia	8	47 0.8×	14 0.7×	13 0.8×	8 0.6×	3 0.3×	13	110
Olivier Mauvais France	6	33 0.6×	23 1.1×	23 1.4×	7 0.5×	6 0.6×	15	87

Countries citing papers authored by Grace Cherry

Since Specialization

Citations

This map shows the geographic impact of Grace Cherry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grace Cherry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grace Cherry more than expected).

Fields of papers citing papers by Grace Cherry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grace Cherry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grace Cherry. The network helps show where Grace Cherry may publish in the future.

Co-authorship network of co-authors of Grace Cherry

This figure shows the co-authorship network connecting the top 25 collaborators of Grace Cherry. A scholar is included among the top collaborators of Grace Cherry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grace Cherry. Grace Cherry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Cherry, Grace. (2021). Immune Checkpoint Inhibitor-Related Adrenal Insufficiency. Seminars in Oncology Nursing. 37(2). 151131–151131. 3 indexed citations

2.

Sisk, Anthony, et al.. (2021). Acute Interstitial Nephritis and PR3-ANCA Following Reintroduction of Pembrolizumab: A Case Report. Immunotherapy. 13(4). 283–288. 4 indexed citations

3.

Shen, John, Jason Y.H. Chang, Melody Mendenhall, et al.. (2018). Diverse cutaneous adverse eruptions caused by anti-programmed cell death-1 (PD-1) and anti-programmed cell death ligand-1 (PD-L1) immunotherapies: clinical features and management. Therapeutic Advances in Medical Oncology. 10. 1960366674–1960366674. 29 indexed citations

4.

Villa, Natalie M., Lin Du, Michael W. Yeh, et al.. (2017). Endocrinopathies with use of cancer immunotherapies. Clinical Endocrinology. 88(2). 327–332. 24 indexed citations

5.

Shin, Daniel S., Ángel García-Díaz, Jesse M. Zaretsky, et al.. (2015). Innate resistance of PD-1 blockade through loss of function mutations in JAK resulting in inability to express PD-L1 upon interferon exposure. Journal for ImmunoTherapy of Cancer. 3(S2). 14 indexed citations

6.

Cherry, Grace, et al.. (1969). Use of vital dyes in the evaluation of the blood supply of the colon.. PubMed. 128(1). 97–102. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact